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Abstract 
Quality of life (QoL) was an important endpoint in the adjuvant breast cancer trials International 
Breast Cancer Study Group (IBCSG) Trial VI and VII. Here, QoL was considered as a time-
dependent effect. The hypothesis explored is that poorer QoL throughout the trial is associated 
with poorer disease-free survival (DFS) and vice-versa. Potential bias in the parameter estimates 
is an important concern associated with missing observations. Standard simple and multiple 
imputation methods were applied to missing QoL assessments before analysis in a time-
dependent Cox model. 7KHUHZDVQRHYLGHQFHWKDWWKHSDWLHQW¶VQoL LVUHODWHGWRWKHSDWLHQW¶V
DFS. 
Keywords 
quality of life; time-dependent Cox model; potential bias; simple imputation; multiple 
imputation; informative missing data  
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1. Introduction 
Clinical judgment of treatment regimens for breast cancer is based on balancing efficacy with 
adverse effects. It is usual that the main treatment comparisons in breast cancer clinical trials are 
based on disease-free survival (DFS) and overall survival (OS). Traditional endpoints such as 
WKHVHGRQRWUHIOHFWWKHSDWLHQW¶VVHQVHRIZHOO-being and thus it is becoming increasingly 
common for quality of life to be assessed throughout the study (Fairclough 2010, p.1). 
7KHSDWLHQW¶VDELOLW\WRFDUU\RXWGD\WRday activities and how the patient feels will influence the 
SDWLHQW¶VSHUFHSWLRQRIZKHWKHUDWUHDWPHQWLVEHQHILFLDODQGWKHSDWLHQW¶VSHUFHSWLRQRIKLVRUKHU
health (Fairclough 2010, p.1). However, these factors are not reflected in traditional endpoints of 
HIILFDF\DQGLQFUHDVLQJO\HQGSRLQWVZKLFKDGGUHVVWKHSDWLHQW¶VSHUFHSWLRQRIKLVRUKHUKHDOWK
are included in clinical trials. The question of whether good quality of life is associated with 
good prognosis is of clinical interest in breast cancer clinical trials (e.g. Epplein et al. 2011; 
Kenne Sarenmalm et al. 2009; Coates et al. 2000). 
The potential problems associated with missing observations, such as missing quality of life 
assessments, include bias of the parameter estimates and loss of power to detect clinically 
important differences among treatment groups over time (Fairclough 2010, chapter 6; Little and 
Rubin 2002, chapter 1 and 3). Methods for dealing with analysis of data with missing 
observations, such as imputation-based procedures, where the missing values are filled-in and the 
completed data are analysed by standard methods, have been proposed in the statistical literature 
(e.g. Rubin 1987; Little and Rubin 2002; Molenberghs and Kenwood 2007). 
Here, standard imputation methods were applied to missing quality of life assessments before 
analysis in a time-dependent Cox model (referring to a Cox proportional hazards model with a 
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time-dependent explanatory variable). The hypothesis explored is that poorer quality of life 
throughout the trial is associated with poorer DFS and conversely better quality of life 
throughout the trial is associated with better DFS. The influence of missing data on explanatory 
variables in time-dependent Cox model analysis in explored by imputing missing quality of life 
scores by standard imputation methods before analysis of DFS. The performance of the standard 
imputation methods is considered by comparing the parameter estimates for quality of life and 
corresponding standard errors. In exploring the hypothesis that quality of life is related to DFS, it 
may be of interest to consider prognostic factors in breast cancer as covariates. An expanded 
time-dependent Cox model based on Herring et al. (2004) was also considered for 
postmenopausal patients (Trial VII). 
2. Patients and Methods 
2.1. IBCSG Trial VI and VII 
Summary of IBCSG Trial VI and VII 
IBCSG Trial VI was designed to examine different durations and timing of adjuvant 
chemotherapy in premenopausal and perimenopausal patients. The trial schema is shown in 
Figure 1. In postmenopausal patients, tamoxifen alone or together with different durations and 
timing of chemotherapy was compared in IBCSG Trial VII. Between July 1986 and April 1993, 
1554 premenopausal and perimenopausal patients were randomized to Trial VI and during the 
same time period 1266 postmenopausal patients were randomized to Trial VII. Data RQSDWLHQW¶V
self-assessed quality of life were prospectively collected throughout the study. Baseline quality 
of life was assessed on, or as close as possible to, the first day of adjuvant therapy. Quality of life 
was recorded approximately 3 months after randomization, then every 3 months until 24 months 
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or recurrence, and again at 1 and 6 months after recurrence. The status of coping scores over 
time is summarized in Table 1. 
Statistical Analysis of Quality of Life in IBCSG Trial VI and VII 
Hürny et al. (1996) found that between baseline and 18 months, there was a significant 
improvement of quality of life over time. There was a significant adverse impact of delayed 
chemotherapy on all quality of life measures. Of note, Hürny et al. (1996) suggested that the 
SDWLHQW¶VTXDOLW\RIOLIe described by the coping score may be related to anticipation of future 
chemotherapy. This implies that the missing coping scores are likely to be informative missing 
data. Previous work by Coates et al. (2000) indicated that in the IBCSG dataset DFS was not 
significantly predicted by quality of life scores at baseline or month 18, or by changes in quality 
of life score between baseline and months 3 or 18. However, Herring et al. (2004) indicated that 
poor baseline quality of life was associated with improved prognosis in postmenopausal patients. 
This may reflect the fact that chemotherapy treatment is fairly toxic. 
The further analysis of quality of life in Trial VI and VII reported here explored the hypothesis 
WKDWWKHSDWLHQW¶VTXDOLW\RIOLIHDVPHDVXUHGE\FRSLQJVFRUHZDVUHODWHGWRWKHSDWLHQW¶V')6
7KHOLQHDUDQDORJXHVFDOHµ+Rw much effort does it cost you tRFRSHZLWK\RXULOOQHVV¶UDQJHG
IURPµQRHIIRUWDWDOO¶WRµDJUHDWGHDORIHIIRUW¶Standard imputation methods are 
applied to impute the missing coping scores in the IBCSG dataset. The square root of the coping 
score (S_Pacis) together with an indicator for delayed chemotherapy is used in a time dependent 
Cox model for DFS. The high proportion of missing coping scores (Table 1) and findings from 
previous statistical analysis of quality of life indicated that imputation is appropriate. Time-
dependent Cox model analyses without imputation was carried out to provide parameter 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 5 
estimates for reference and illustrative purposes (Table S2; online appendix only). Schoenfeld 
residuals against time were plotted for the explanatory variables in this time-dependent Cox 
model analysis (Figure S1; online appendix only). The dataset for the analysis of all available 
coping scores contains patients with a monotone missing data pattern and patients with 
intermittent missing coping scores. The time-dependent Cox model analysis of all available 
coping scores considered 2544 patients. An expanded time-dependent Cox model analysis based 
on Herring et al. (2004), which consider prognostic factors in breast cancer as covariates, was 
also performed on the postmenopausal patients (Trial VII) (Table 3). 
Parameters in the Time Dependent Cox Model 
The statistical analysis of efficacy (The International Breast Cancer Group 1996; The 
International Breast Cancer Group 1997) and previous statistical analysis of quality of life by 
Herring et al. (2004) suggested also including an indicator for sufficient early chemotherapy and 
estrogen positive receptor status in the time dependent Cox model. Sufficient early 
chemotherapy was defined as 6 initial cycles of CMF in Trial VI and 3 initial cycles of CMF in 
Trial VII. This was not done in the analyses reported here to keep the model parsimonious and 
for ease of comparison of the standard imputation methods. 
Parameters in the Expanded Time Dependent Cox Model for Postmenopausal Patients 
(Trial VII) 
The expanded time-dependent Cox model analysis for postmenopausal patients included the 
covariates and interaction terms considered by Herring et al (2004). The treatment covariates are 
coded so that women who took tamoxifen only are the reference group. Interaction terms for 
treatment and age and interaction terms for treatment and estrogen receptor status were 
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considered. As in Herring et al. (2004), the original coping score was reversed so that higher 
coping scores indicated higher quality of life. However, as the full IBCSG Trial VII dataset is 
XVHGLQVWHDGRIDQLQGLFDWRUIRUZKHWKHUWKHSDWLHQW¶VSULPDU\ODQJXDJHLV*HUPDQ
language/culture groups were defined. The reference language/culture group is German/Germany 
and Switzerland. 
Standard Imputation Methods 
The standard simple imputation methods applied to the IBCSG dataset were: 
i) LOCF 
ii) median imputation by patient 
iii) linear regression with previous coping score(s) 
Fifty repetitions of standard multiple imputation methods were performed. The standard multiple 
imputation methods applied to the IBCSG dataset were: 
i) bootstrapping: subgroups defined by baseline coping score or previous coping score 
ii) nearest neighbor imputation 
iii) predictive mean matching 
iv) pattern mixture models ± &XUUDQ¶VDQDO\WLFDOWHFKQLTXH 
2.2. Technical Details of Standard Imputation Methods 
As noted, there were 2687 patients randomized to Trial VI and VII. However, some patients 
could not be considered in the time-dependent Cox model analysis following standard imputation 
methods. The 456 patients with a missing baseline coping score (approximately randomization) 
were only considered in the time-dependent Cox model analysis after median imputation by 
patient. 
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When considering the remaining standard imputation methods, 15 patients where using the 
expected dates of assessment for missing coping scores led to intervals of less than 1 day for the 
time-dependent Cox model analysis were not considered. The corresponding number was 18 
patients when considering median imputation by patient. The status of the coping scores 
considered for time-dependent Cox model analysis at each time point considered is summarized 
in Table S1 (online appendix only). 
When considering multiple imputation methods, calculations during the imputation by the MI 
procedure in SAS were based on standardised values of S_Pacis. Further details on implementing 
the standard imputation techniques are described below. 
Bootstrapping 
The patients were divided into 9 subgroups according to i) the baseline coping score and ii) the 
previous coping score as defined in Table S3 (online appendix only). For each missing coping 
score, the set of potential imputed values is all the observed coping scores at the same time 
period among the patients in the same subgroup as the patient with the missing coping score. The 
imputed coping score was selected at random from the set of potential imputed values by proc 
surveyselect in SAS. 
Nearest Neighbor Imputation and Predictive Mean Matching 
A monotone missing monotone pattern was created by imputing non-monotone missing coping 
scores by LOCF. Nearest neighbor imputation (Rubin 1987, chapter 5; Van Buuren et al. 1999) 
was then implemented by using the regpredmeanmatch procedure option in the monotone 
statement in the MI procedure in SAS. During the imputation, predicted values for patients with 
both observed values and missing observation were generated from a linear regression model. 
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The linear regression model for S_Pacis considered at each time point was based on the previous 
coping score(s). Predictive mean matching (Rubin 1987, p.168, Rubin and Schenker 1991; 
Heitjan and Landis 1994) was implemented similarly to nearest neighbor imputation. The five 
patients with an observed value where the predicted value was closest value to the predicted 
value for the patient with the missing value were considered when selecting the imputed value. 
Pattern Mixture Models &XUUDQ¶V$QDO\WLF7HFKQLTXH 
Pattern mixtures models (Little 1993; Little 1994; Little 1995) is a modelling approach to 
multiple imputation. The method stratifies incomplete data by the pattern of missing values and 
formulates distinct models within each stratum (Little and Wang, 1996). It is common that the 
parameters for many of these models can only be estimated by imposing restrictions (Fairclough 
2010, p. 213). Thus, restrictions such as the complete case missing value restriction (CCMV) 
have been proposed for longitudinal data with monotone missing data. Under the CCMV 
restriction, the data for patients with complete data are used to predict the means for the missing 
observations in the remaining patterns. Curran (2000) proposed an analytic technique for such 
restrictions using multiple imputation by the Markov chain Monte Carlo (MCMC) method of 
data augmentation. 
A monotone missing data pattern was created by imputing non-monotone missing coping scores 
E\/2&)&XUUDQ¶VDQDO\WLFWHFKQLTXHZDVWKHQ implemented using the MI procedure in SAS 
(see algorithm in the online appendix). During the imputation, S_Pacis Yh (h = 1,..,9) were 
assumed to follow a multivariate Normal distribution. Default settings for the MCMC statement 
applying MCMC methods in the MI procedure in SAS were used. Therefore, during the 
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imputation i) a single chain was used and ii) a non-informative Jeffreys prior was used to derive 
the posterior mode from the EM algorithm as the starting values. 
3. Results 
The plots of Schoenfeld residuals (Schoenfeld 1982) against time for S_Pacis and delayed 
chemotherapy from the time-dependent Cox model analysis of all available coping scores is 
shown in Figure S1 (online appendix only). Beyond approximately 11 years (~ 4000 days), the 
plots no longer indicated a zero slope for delayed chemotherapy (Figure S1B). However, this did 
not raise concerns about the time-dependent Cox model. The parameter estimates from this time-
dependent Cox model analysis are shown in Table S2 (online appendix only). The bias in 
considering all available coping scores in the IBCSG dataset makes it difficult to interpret the 
parameter estimates. The results from the time-dependent Cox model analysis following standard 
imputation methods are shown in Table 2. 
Applying Standard Imputation Methods to the IBCSG Dataset 
Given the indication that the missing coping scores in the IBCSG dataset are informative missing 
data, it is unlikely that the assumptions for the standard simple imputation methods hold. Many 
multiple imputation methods assume a monotone missing data pattern, which is not the case the 
IBCSG dataset. In the standard multiple imputation methods except from bootstrapping, the non-
monotone missing data patterns were imputed by LOCF. 
Parameter Estimate of Square Root for Coping Score and Delayed Chemotherapy 
The parameter estimate for S_Pacis was positive, favoring a positive relationship between 
quality of life and DFS, for all standard imputation methods (Table 2). The multiple imputation 
methods showed hazard ratios which were similar for each repetition. The parameter estimate for 
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S_Pacis was close to 0 for all standard imputation methods. As noted, in Herring et al. (2004) 
poor baseline coping score was associated with improved relapse-free survival in 
postmenopausal patients. However, considering coping scores throughout the study in a time-
dependent Cox model led to parameter estimates in the opposite direction and of a smaller 
magnitude. There was no evidence from the standard simple or standard multiple imputation 
methods of a statistically significant or clinically important relationship between quality of life 
and DFS. This was consistent with the expanded time-dependent Cox model analysis of 
postmenopausal patients (Trial VII) based on Herring et al (2004) (Table 3). 
The parameter estimate for delayed chemotherapy was negative, favoring a positive relationship 
between further treatment with delayed chemotherapy and DFS, for all standard imputation 
methods (Table 2). The time-dependent Cox model analysis indicated a trend towards a positive 
relationship between delayed chemotherapy and DFS. 
Standard Error of Parameter Estimate for Square Root of Coping Score and Delayed 
Chemotherapy 
The standard error of the parameter estimate for S_Pacis (~0.011) and delayed chemotherapy 
(~0.054) following simple imputation methods (Table 2) was approximately equal to the 
standard error considering all available coping scores (Table S2). The standard errors of the 
parameter estimates following simple imputation have not increased to reflect the uncertainty in 
the imputed values. In contrast, the standard errors of the parameter estimates following multiple 
imputation showed a small increase to reflect this uncertainty. The standard error of the 
parameter estimate for S_Pacis and delayed chemotherapy increased by ~14% to ~0.0125 (Table 
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2) compared to ~0.011 (Table S2) and by ~4% to ~0.056 (Table 2) compared to ~0.054 (Table 
S2) respectively. 
Expanded Time-Dependent Cox Model Analysis for Postmenopausal Patients 
The expanded time-dependent Cox model analysis of postmenopausal patients (Trial VII) 
considered three scenarios: i) all available coping score, ii) simple imputation by LOCF and iii) 
multiple imputation by bootstrapping, subgroups defined by baseline coping score. For each of 
the 3 scenarios, there was no evidence of a clinically a statistically significant or clinically 
important relationship between quality of life and DFS. The parameter estimate for S_Pacis was 
close to 0 (Table 3). 
4. Summary 
We investigated the influence of missing quality of life values, as assessed by coping score, 
when exploring the relationship between quality of life and DFS in a time-dependent Cox model. 
Preliminary investigations indicated that imputation is appropriate for the IBCSG dataset. 
Standard imputation methods were applied to the IBCSG dataset before analysis in a time-
dependent Cox model. While the standard imputation methods are not necessarily good 
estimation techniques in this context due to the assumptions relating to the missing data 
mechanism and the missing data pattern, this provides insight into the influence of the missing 
quality of life assessments in the time-dependent Cox model analysis. 
There are only limited circumstances when it is appropriate to draw inferences from the 
parameter estimate resulting from simple imputation. Justification should be provided if the 
parameter estimates are considered (Molenbergs and Kenward 2007, Chapter 4). However, the 
purpose of applying simple imputation methods is generally as part of a sensitivity analyses into 
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the sensitivity of results to the assumptions about the missing data. Many multiple imputation 
methods assume a monotone missing data pattern, which is not the case the IBCSG dataset. In 
the standard multiple imputation methods except bootstrapping, the non-monotone missing data 
patterns were imputed by LOCF. This gives the advantage of generating multiple completed 
datasets compared to LOCF imputation. 
The parameter estimate for S_Pacis was positive, favoring a positive relationship between 
quality of life and DFS, for all standard imputation methods. There was no evidence from the 
standard imputation methods of a statistically significant or clinically important relationship 
between quality of life and DFS in the IBCSG dataset. As noted, the standard error of the 
parameter estimates following simple imputation did not increase compared to considering all 
available coping scores and thus did not reflect the uncertainty in the imputed values. In contrast, 
there was a small increase in the standard error of the parameter estimates following the standard 
multiple imputation methods. The parameter estimates for delayed chemotherapy showed a trend 
towards a positive relationship between delayed chemotherapy and DFS. This is consistent with 
the finding from the main efficacy analysis that there may be a therapeutic benefit from delayed 
chemotherapy. 
The parameter estimates for S_Pacis and delayed chemotherapy following the standard 
imputation methods were similar to those from the all available analysis. This is similar to the 
fact that the parameter estimates for baseline coping score in Herring et al. (2004) were little 
influenced by the different models accounting for missing data. However, as noted, the bias from 
the selection of patients considered in the all available analysis makes it difficult to interpret the 
values of the parameter estimates. The small increase in the standard error of the parameter 
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estimates compared to the all available analysis was similar following each of the standard multiple 
imputation methods. The similarities in the parameter estimates and standard errors may be influenced by 
the fact there is no evidence of a statistically significant or clinically important relationship between 
quality of life and DFS in the IBCSG dataset. 
Considering coping scores throughout the study in a time-dependent Cox model led to parameter 
estimates in the opposite direction and of a smaller magnitude than when considering baseline quality of 
life in Herring et al. (2004). There are differences of note in the time-dependent Cox model analyses 
described here compared to Herring et al. (2004). Firstly, here premenopausal patients and 
postmenopausal patients outside Switzerland were considered, giving a broader and larger population of 
patients. Secondly, the outcome of relapse-free survival considered by Herring et al. (2004) did not 
include second primary cancer or death without prior event as events. Lastly, further covariates such as 
age and interaction terms were considered in the analysis by Herring et al. (2004), whereas the time-
dependent Cox model analysis was parsimonious. Of note, the expanded time-dependent Cox model 
analysis of postmenopausal patients (Trial VII) based on Herring et al (2004) also found no evidence of a 
statistically significant or clinically important relationship between quality of life and DFS. 
It is possible that the performance of the standard imputation methods in this setting is influenced by the 
fact that here there was no evidence of a relationship between quality of life and DFS. It would be of 
interest to investigate if the performance of the standard imputation methods is influenced by the 
relationship between quality of life and DFS in datasets where quality of life was associated with DFS. 
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Table 1. Summary of Status of Coping Scores in IBCSG Trial VI and VII. 
    
Observed Missing 
Post-
recurrence 
Lost to 
follow-up Dead 
Time 
1 Baseline 2231 (83.0) 456 (17.0) 0 (  0.0) 0 (  0.0) 0 (  0.0) 
Time 
2 Month 3 1918 (71.4) 744 (27.7) 25 (  0.9) 0 (  0.0) 0 (  0.0) 
Time 
3 Month 6 1871 (69.6) 751 (27.9) 56 ( 2.1) 1 (  0.0) 8 (  0.3) 
Time 
4 Month 9 1817 (67.6) 745 (27.7) 103 (  3.8) 1 (  0.0) 21 (  0.8) 
Time 
5 Month 12 1812 (67.4) 662 (24.6) 173 (  6.4) 3 (  0.1) 37 (  1.4) 
Time 
6 Month 15 1692 (63.0) 711 (26.5) 215 (  8.0) 3 (  0.1) 66 (  2.5) 
Time 
7 Month 18 1616 (60.1) 707 (26.3) 266 (  9.9) 5 (  0.2) 93 (  3.5) 
Time 
8 Month 21 1556 (57.9) 693 (25.8) 294 (10.9) 5 (  0.2) 139 (  5.2) 
Time 
9  Month 24 1502 (55.9) 666 (24.8) 339 (12.6) 5 (  0.2) 175 (  6.5) 
Data are n (%) 
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Table 2. Summary of Time Dependent Cox Model Analysis Considering Square Root of 
Coping Score (S_Pacis) and Delayed Chemotherapy Stratified by Trial. 
Square root of coping score (S_Pacis)       
Method Detail 
Parameter 
estimate Range 
Standard 
error t statistic 
95% CI for 
hazard ratio 
LOCF   0.0047   0.0112 0.42 (0.983, 1.027) 
Median  by patient 0.0136   0.0107 1.27 (0.993, 1.035) 
Linear 
regression 
previous 
coping 
scores 0.0069   0.0124 0.56 (0.983, 1.032) 
Bootstrap 
baseline 
coping 
score 0.0046 -0.0096 to 0.0195 0.0130 0.35 (0.979, 1.030) 
  
previous 
coping 
score 0.0070 -0.0027 to 0.0194 0.0125 0.56 (0.983, 1.032) 
Nearest neighbor 0.0030 -0.0037 to 0.0108 0.0118 0.25 (0.980, 1.026) 
Predictive 
mean 
matching 
initial steps 
as described 
for NNI 0.0043 -0.0026 to 0.0149 0.0121 0.36 (0.981, 1.028) 
Pattern mixture models 0.0127 0.0061 to 0.0231 0.0123 1.03 (0.989, 1.037) 
Delayed Chemotherapy 
    
  
Method Detail 
Parameter 
estimate Range 
Standard 
error t statistic 
95% CI for 
hazard ratio 
LOCF   -0.0929   0.0555 -1.67 (0.817, 1.016) 
Median  by patient -0.1124   0.0521 -2.16 (0.807, 0.990) 
Linear 
regression 
previous 
coping 
scores -0.0937   0.0556 -1.69 (0.817, 1.015) 
Bootstrap 
baseline 
coping 
score -0.0929 -0.0968 to -0.0884 0.0556 -1.67 (0.802, 1.020) 
  
previous 
coping 
score -0.0937 -0.0976 to -0.0907 0.0556 -1.69 (0.802, 1.020) 
Nearest neighbor -0.0926 -0.0948 to -0.0905 0.0560 -1.65 (0.802, 1.021) 
Predictive 
mean 
matching 
initial steps 
as described 
for NNI -0.0928 -0.0963 to -0.0909 0.0555 -1.67 (0.803, 1.020) 
Pattern mixture models -0.0956 -0.1009 to -0.0933 0.0556 -1.72 (0.800, 1.018) 
CI = confidence interval; NNI = nearest neighbor imputation 
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Note: The standard error shown is the square root of the variance of the parameter estimate. The standard 
error and the parameter estimate are used to calculate the 95% confidence interval for the parameter 
estimate. The exponential of the lower and upper 95% confidence limits for the parameter estimate gives 
the lower and upper 95% confidence limits for the hazard ratio. The t-statistic is the parameter estimate 
divided by the standard error. 
For the multiple imputation methods, the parameter estimate is the mean of the parameter estimate from 
each of the 50 completed datasets. The variance of the parameter estimate for each of the multiple 
imputation methods is calculated based on the 50 repetitions of multiple imputation according to Rubin 
(1987). 
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Table 3. Summary of Expanded Time-Dependent Cox Model Analysis of Postmenopausal 
Patients (IBCSG Trial VII). 
Parameter All Available LOCF Bootstrapping* 
  Estimate Standard Error Estimate Standard  Error Mean Estimate 
Main Effects           
Early CMF -0.3860 0.2369 -0.4347 0.2578 -0.4282 
Late CMF 0.1620 0.2284 0.2189 0.2520 0.2225 
Full CMF -0.3038 0.2306 -0.2150 0.2483 -0.2091 
Number nodes positive 0.0715 0.0066 0.0807 0.0073 0.0809 
Age >= 65 -0.2339 0.1690 -0.2331 0.1869 -0.2361 
Positive ER status -0.1837 0.1827 -0.1246 0.2014 -0.1237 
S_Pacis 0.0096 0.0168 0.0095 0.0181 -0.0017 
      
  
    
Language/culture Main Effects           
Language/culture EngAusNz -0.1535 0.1322 -0.2496 0.1417 -0.2604 
Language/culture EngSA -0.1036 0.2029 -0.2193 0.2069 -0.2380 
Language/culture FrenchCH -0.1797 0.1766 -0.2339 0.1978 -0.2334 
Language/culture ItalianCH -0.2073 0.1933 -0.3047 0.1960 -0.3026 
Language/culture ItalianI -0.3780 0.1376 -0.4526 0.1434 -0.4448 
Language/culture SlovenianSl -0.1740 0.1499 -0.2872 0.1640 -0.2758 
Language/culture SpanishSp 0.1109 0.2631 0.1350 0.2808 0.1496 
Language/culture SwedishSd 
-0.3890 0.1274 -0.5387 0.1423 -0.5457 
  
 
  
 
  
  
Treatment Interactions 
 
  
 
  
  
Early CMF * Age >= 65 0.4623 0.2434 0.3155 0.2720 0.3110 
Late CMF * Age >= 65 0.0244 0.2550 0.1357 0.2756 0.1292 
Full CMF * Age >= 65 0.3312 0.2416 0.3764 0.2604 0.3823 
Early CMF * Positive ER status 0.0161 0.2612 0.1573 0.2850 0.1562 
Late CMF * Positive ER status -0.4555 0.2556 -0.4796 0.2807 -0.4755 
Full CMF * Positive ER status -0.0514 0.2557 -0.1588 0.2757 -0.1618 
*For imputation by bootstrapping, the subgroups were defined by baseline coping score. Based 
on 50 repetitions of multiple imputation, the standard error of the parameter estimate for S_Pacis 
was 0.0201. 
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Note: Higher coping scores indicated higher quality of life 
Reference group for treatment is tamoxifen only 
Reference group for language/culture is German/Switzerland and Germany 
CMF = cyclophosphamide, methotrexate and fluorouracil; ER = estrogen receptor 
Abbreviations for language or countries in language/culture groups:  
Eng = English; AusNZ =Australia and New Zealand; SA = South Africa; CH = Switzerland; I = 
Italy; Sl = Slovenia; Sp =Spain; Sd= Swedan; 
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